TheEdgeResearch
Home / Stocks / ELTX

Elicio Therapeutics, Inc. (ELTX)

NASDAQ Healthcare Biotechnology
$1.45 ▼ -3.33%
Market Cap
$27.6M
Sector
Healthcare
Industry
Biotechnology
Beta
1.98
52-Wk Range
1.25-16
CEO
Robert T. Connelly
Country
US
Currency
USD

Elicio Therapeutics, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Boston, MA, US. The stock last traded at $1.45, down 3.33% on the session, giving a market capitalisation of $27.6M. On trailing twelve-month figures it carries a trailing P/E of -0.79, a net margin of 0.0%. Its beta of 1.98 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.79
Price / Sales
0.00
Price / Book
2.02
EV / EBITDA
-0.28
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.74
Current ratio
3.43
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
33
IPO date
2021-02-05
Headquarters
Boston, MA, US
About Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.

Comparable companies

Elicio Therapeutics, Inc. is most often compared with the following Healthcare names:

ACTUAPLTCRBPCRDFMISTMOLNNKTXPEPGRANISAVA
More research on ELTX
ELTX technical analysis ELTX TheEdge Score Compare against peers
Open full interactive analysis & DCF →